8-K

US NUCLEAR CORP. (UCLE)

8-K 2024-12-12 For: 2024-12-12
View Original
Added on April 06, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the SecuritiesExchange Act of 1934

Date of Report (Date of earliest event reported): December 12, 2024

US NUCLEAR CORP
(Exact name of registrant as specified in its charter)
Delaware 000-54617 45-4535739
--- --- ---
(state or other jurisdiction <br><br>of incorporation) (Commission File Number) (IRS Employer <br><br>Identification Number)
7051 Eton Avenue Canoga Park, CA 91303
--- ---
(address of principal executive offices) (zip code)
(818) 883-7043
---
(registrant’s telephone number, including area code)

Not Applicable
(former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section12(b) of the Act: None.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election ofDirectors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Effective October 6, 2023, Michael Pope was appointed as a director of the Company. Mr. Pope has without warning become incommunicado and non-responsive, thus making Board Actions difficult. On December 9, 2024, the Board voted to revoke Mr. Pope’s board membership until such time he has may reconnect with the Chairman of the Board, Robert Goldstein.

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

US NUCLEAR CORP
Date: December 12, 2024 /s/ Robert Goldstein
Robert Goldstein
Chief Executive Officer

2